Rhythm Pharmaceuticals (RYTM) PT Raised to $129 at Morgan Stanley
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street rallies after Democrats win Congress; data center stocks slide
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
| (NASDAQ: RYTM) | Delayed: 86.07 -0.37 (0.43%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $86.44 | 52 Week High | $ | |||
| Open | $85.94 | 52 Week Low | $ | |||
| Day High | $87.77 | P/E | N/A | |||
| Day Low | $85.04 | EPS | $ | |||
| Volume | 365,059 | |||||
